子类别 期刊論文 [19/20] 會議論文/會議摘要 [7/11] 邻近社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 社群统计 近3年内发表的文件:0(0.00%) 含全文笔数:26(83.87%) 文件下载次数统计 下载大于0次:26(100.00%) 下载大于100次:26(100.00%) 全文下载总次数:23644(0.44%) 最后更新时间: 2024-12-01 11:25 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Phase I study of biweekly liposome ... A phase I dose escalation study of ... Phase I dose-escalation study of so... Activation of Akt/FoxO axis confers... Concurrent chemoradiotherapy with c... Concurrent chemoradiotherapy with c... Randomised clinical trial: Comparis... Early data from a phase I study of ... Combination of arsenic trioxide and... Novel feedback inhibition of surfac...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目11-20 / 31. (共4页) << < 1 2 3 4 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2010-06	Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma	Annals of Oncology. 2010 Jun;21(Suppl. 6):27.
2009-12	Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent	Journal of Clinical Oncology. 2009 Dec;27(36):e271.
2009-11	Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer	Cancer Chemotherapy and Pharmacology. 2009 Nov;64(6):1173-1179.
2009-09	Synergistic augmentation of arsenic trioxide-induced cytotoxicity by BCNU through reactive oxygen species-related autophagic pathway in human solid tumors	EJC Supplements. 2009 Sep;7(3):16.
2009-05-20	Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC)	Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number 4587.
2007-11-15	Tamoxifen accelerates proteasomal degradation of O-6-methylguanine DNA methyltransferase in human cancer cells	International Journal of Cancer. 2007 Nov;121(10):2293-2300.
2007-03-01	Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036	Biochemical Pharmacology. 2007 Mar;73(5):610-619.
2007-01	D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation	Molecular Cancer Therapeutics. 2007 Jan;6(1):193-202.
2006-11	Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma	Cancer Chemotherapy and Pharmacology. 2006 Nov;58(5):654-664.
2006-11	D-501036, a novel selenophene-base triheterocycle derivative exhibits potent in vitro and in vivo anti-tumoral activity, which involves DNA-damage and ATM activation	EJC Supplements. 2006 Nov;4(12):92.

显示项目11-20 / 31. (共4页) << < 1 2 3 4 > >> 每页显示[10|25|50]项目